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Abstract
Background:  An influenza pandemic may have considerable impact on health and societal
functioning. The aim of this study was to explore people's reflections on the consequences of a
pandemic.
Methods: Cross-sectional web-based survey of 1,168 Norwegians aged 16–82 years. The main
outcome measures were answers to questions about a potential pandemic ("serious influenza
epidemic"): statements about personal precautions including stockpiling Tamiflu®, the perceived
number of fatalities, the perceived effects of Tamiflu®, the sources of information about influenza
and trust in public information.
Results: While 80% of the respondents stated that they would be "careful about personal hygiene",
only a few would stay away from work (2%), or move to an isolated place (4%). While 27% of
respondents were uncertain about the number of fatalities during an influenza pandemic, 48%
thought it would be lower than the estimate of Norwegian health authorities (0.05%–1%) and only
3% higher. At least half of the respondents thought that Tamiflu® might reduce the mortality risk,
but less than 1% had personally purchased the drug. The great majority had received their
information from the mass media, and only 9% directly from health authorities. Still the majority
(65%) trusted information from the authorities, and only 9% reported overt distrust.
Conclusion: In Norway, considerable proportions of people seem to consider the mortality risk
during a pandemic less than health authorities do. Most people seem to be prepared to take some,
but not especially disruptive, precautions.
Background
Soon, a longer time will have elapsed since the last human
influenza pandemic (1968) than between the previous
two pandemics (1918 and 1957). During the last year,
transmission of avian influenza to humans has been
reported in several countries. Up until now there has been
no evidence that avian influenza is able to spread among
humans, but if this were to happen, a pandemic would be
likely to develop. Experts at WHO believe that "the world
is now closer to another influenza pandemic than at any
time since 1968" [1], and the consequences may be con-
siderable both in terms of fatalities and resource use [2,3].
The Norwegian Institute of Public Health states that peo-
ple have "some reason to be scared" of a pandemic and
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indicates that 0.05%–1% of the population might die dur-
ing an influenza pandemic [4]. This estimate is in accord-
ance with the observed 0.65% in the US during the
Spanish Flu (675,000 [5] out of a population of 103 mil-
lions [6]).
In 2005, to prepare for a pandemic, the Norwegian Gov-
ernment stockpiled oseltamivir (Tamiflu®) in quantities
equivalent to 1.4 million courses of treatment for a total
population of 4.6 millions. In general the possibilities of
a pandemic have created considerable public concern, not
least because of extensive media coverage of the global
influenza situation and several reports of avian influenza
in humans.
The current situation raises issues beyond the core public
health challenges. First, what are people's sources of infor-
mation about influenza pandemics, and do people trust
the information they receive from public sources? If they
do, health authorities will be better able to manage the
consequences of a pandemic. Second, what are people's
perceptions of the mortality risk during an influenza pan-
demic, and are they in line with the predictions from pub-
lic health authorities? Third, what precautions might
people take to protect themselves during a pandemic? If a
considerable proportion of the population gives up nor-
mal activities such as work to protect themselves, this
might disrupt social functions such as health care, polic-
ing and communication. The consequences may be devas-
tating, at least in the short term, even if the death toll were
moderate.
Methods
TNS Gallup has developed an internet-based panel of
about 25,000 Norwegians aged 15 years and over. The
panel members have volunteered to respond to question-
naires via internet. E-mail alerts are sent when a question-
naire is ready to be filled in on the internet. The members
receive bonus points each time they participate in a sur-
vey, and the points can be used to purchase household
articles, etc. The response rate is typically 70–80%, and the
survey is finalised when a pre-specified number of
responses are obtained. For financial reasons, this study
was restricted to 1,000 questionnaires among individuals
aged 15–67 years of age, and 165 aged 68+. In total, 1,500
individuals aged 15–68 and 250 aged 68+ were invited,
randomly chosen among the 25,000 panel members. In
practice 1004+164 (78%) respondents filled in the ques-
tionnaire. The agreed number of responses was achieved
earlier (3 days after the e-mail alert in early November
2005) than is usual for such surveys. The study was under-
taken at a time when national and international mass
media were very concerned about the pandemic threat [7].
The questionnaire (see appendix) posed eight questions
about a potential "serious influenza outbreak": precau-
tions during such an outbreak; the likely number of fatal-
ities in Norway (i.e. the perceived risk in a population of
4.6 million); the number of avoided fatalities if Tamiflu®
were available to everybody (i.e. the absolute risk reduc-
tion, ARR); the maximum that respondents were willing
to pay for a course of Tamiflu® (paper accepted in Health
Economics); whether they already had got hold of Tami-
flu®; their sources of information about influenza;
whether they trusted information provided by authorities;
and self reported health. We chose to use the term "serious
influenza outbreak" because we thought that many
respondents might not be familiar with the term pan-
demic.
In the analysis of fatality data, we assumed that all fatali-
ties and avoided fatalities would occur during a one year
period. The respondents' perceived risks and Tamiflu®-
effects can then be used to calculate one year mortality
rates and absolute risk (incidence) reductions (ARR). The
ARR was translated to numbers-needed-to-be-treated
(NNT) by taking the reciprocal of ARR. Relative risk reduc-
tion from Tamiflu® was calculated on the basis of mortal-
ity rates without Tamiflu® and the respondents' reported
ARR.
Information on age, sex, marital status, education, place
of residence, and family income had been previously col-
lected in 2005 for the whole panel. Along with self
reported health and perceived risk, these variables were
used as determinants of responses in multivariable logis-
tic regression analyses. Data were analysed in SPSS and
SAS.
Results
The mean age of the respondents was 45 years (median
45, range 16–82) and 45% were female (Table 1). The
respondents were fairly representative of the general pop-
ulation with respect to age, proportion of people living
alone, and place of residence. Men and people with high
income and education were somewhat overrepresented.
The majority of respondents had received information
about influenza from the mass media (TV: 89%, newspa-
pers: 85%, periodicals: 4%); a few directly from health
authorities via internet or "influenza-phones" (Institute of
Public Health: 2%, Food Safety Authority: 3%, GPs: 4%,
Directorate of Health: 1%). Seventy-nine per cent of the
respondents had received information from the mass
media only. Sixty-five per cent trusted the information
they had received directly or indirectly from authorities,
while 9% distrusted it. In logistic regression, the odds for
reporting overt distrust in or doubts about the informa-
tion were greater among younger people (age < 45 years vsBMC Public Health 2007, 7:48 http://www.biomedcentral.com/1471-2458/7/48
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45+, OR 1.9, 95% CI 1.4 – 2.4), those with poor self-
reported health (poorer than "very good" vs "very good",
OR 1.5, 95% CI 1.2 – 2.0), those with poor education
(<14 years vs 14+, OR 1.4, 95% CI 1.1 – 1.8), those with a
high perceived mortality risk (10,000+ deaths vs <10,000,
OR 1.7, 95% CI 1.2 – 2.3) and people living in one spe-
cific region (south-west, OR 1.6, 95% CI 1.2 – 2.2 relative
to the central region).
About one quarter of the respondents were uncertain
about the mortality risk (number of fatalities) from a seri-
ous influenza epidemic, whereas the majority indicated it
to be less than 1% (Table 2). For 48% of respondents the
perceived risk was lower than predicted by the health
authorities. Relative risk reduction (RRR) and the number
needed to be treated (NNT) with Tamiflu® were calculated
except for respondents who were uncertain about the
input numbers or indicated a greater number of fatalities
with Tamiflu®  than without. Among respondents for
whom we could calculate RRR and NNT, the vast majority
of NNTs were above 1,000 and half of RRRs greater than
50% (Table 2). In total, only 12 (1%) of the respondents
had purchased Tamiflu®.
According to their responses, 80% would be "careful
about personal hygiene", 9% would use face masks when
outdoors, 2% would stay off work, 11% would stay at
home and avoid contact with others, 4% would move to
an isolated area (country side cottage, farm, etc.) while
16% would not take any special precautions if a serious
influenza pandemic should break out. In logistic regres-
sion analysis, the odds for reporting isolation (i.e. stay
home, stay off work or move to an isolated place) as a pre-
caution were greater among those with poor self-reported
health (poorer than "very good" vs "very good", OR 1.8,
95% CI 1.3 – 2.6) and those with high perceived fatality
risk (10,000+ deaths vs <10,000, OR 3.2, 95% CI 2.2 – 4.8
compared to < 10,000 deaths).
Discussion and conclusion
The results of this study indicate that most people con-
sider influenza pandemic to be a public health threat, but
about half of the respondents considered the mortality to
be lower than predicted by the health authorities. Moreo-
ver, relatively few seem prepared to take precautions that
would seriously disrupt their normal social functions. Few
have purchased Tamiflu® even though many consider it to
be effective in preventing fatalities. The results, however,
should be seen in terms of the limitations of the study.
The study sample was not entirely representative of the
adult Norwegian population in that women, poorly edu-
cated people, and those with lower incomes were some-
Table 1: Sociodemographic variables of lay people aged 16 – 82 (n = 1,168) responding to an internet survey about a serious influenza 
epidemic
Sample Norwegian population
Agea
15 – 29 21 % 23 %
30 – 44 28 % 28 %
45 – 59 29 % 25 %
60 + 22 % 23 %
Proportion femalea 45 % 51 %
Proportion living aloneb 16 % 16 %
Years of Educationa
0 – 10 14 % 21 %
11 – 13 53 % 55 %
14 + 33 % 24 %
Region of Recidencea
Central 51 % 50 %
Southern/western 31 % 31 %
Middle/northern 18 % 19 %
Source of incomec
Work 61 % 64 %
Pension (old age) 15 % 7 %
National Insurance 7 % 10 %
Other 17 % 19 %
Household incomea (€1.00 = NOK8.00)
€67,150 €57,188d
a) Compared to the Norwegian population aged 15+
b) Compared to the entire Norwegian population
c) Compared to the Norwegian population aged 16 – 74
d) Average household income in 2003 according to Statistics NorwayBMC Public Health 2007, 7:48 http://www.biomedcentral.com/1471-2458/7/48
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what underrepresented. Numeracy is a problem when
asking people about fatality risk, but we asked about the
number of fatalities instead of risk estimates because "nat-
ural frequencies" are known to be better understood than
probabilities [8]. Still, 3% of the respondents indicated a
greater number of avoided fatalities from using Tamiflu®
than the number without any treatment. When comput-
ing mortality rates, we assumed that the respondents esti-
mated the number of fatalities or avoided fatalities for a
Norwegian population of 4.6 million. To the extent that
this assumption does not hold, our risk estimates are
imprecise. While the responses to the question about
Tamiflu®  purchase were based on actual behavior in
present time, statements about precautions were based on
intentions given thata pandemic hits Norway some time
in the future. Consequently, the reported behavior during
a pandemic may suffer from hypothetical bias. Such bias
is likely since the majority of respondents will have lim-
ited or no information on the implications of a pandemic
such as the Spanish Flu, and the lack of experience and
information may clearly lead to respondents being rather
uncertain about their true behaviour in such extraordinary
circumstances.
That respondents were faced with only a few simple ques-
tions is a strength of the study. The rapid response to the
questionnaire is an indication that people considered the
issues to be important. The results seem germane to public
health and crisis policy managers. First, the majority trusts
the information they receive from health authorities even
though many receive this information through mass
media that tend to frighten or exaggerate in order to
receive attention (less than 10% had sought information
directly from health authorities websites or call systems).
The highest selling newspaper wrote at one stage that
about 25% of the population might die during a pan-
demic. In contrast, health authorities have indicated a
mortality risk in the order of 0.05–1%, and about half of
the respondents perceived the risk to be even lower than
this. It is reassuring that an occasional "shock headline"
seems to have little impact on people's risk perceptions,
but also somewhat intriguing that the public in the light
of extended media coverage have a tendency to underesti-
mate the risk of mortality. Overall, it must be concluded
that the media coverage has been balanced, or alterna-
tively, the members of the public have effectively screened
the flow of information that reached them. No more than
about one in ten seems to be prepared to stay off work or
move to isolated locations to protect themselves. Even
though these results are based on hypothetical considera-
tions, they indicate that few are prepared to take precau-
tions that would disrupt vital functions of society. If
authorities manage to avoid panic during a pandemic, the
consequences may not be disastrous to social functioning
unless fatality numbers get too high. It is worthwhile not-
ing that the majority will take some precautions, and a
pandemic will almost certainly have impact on travelling
and other aspects of social and economic life. It seems
contradictory when 11% said they would avoid contacts
with others while only 2% would stay away off work. Pre-
sumably, most would go to work, but stay away from oth-
ers the rest of the time. As many as 80% of the
respondents would be more "careful about personal
hygiene". Unfortunately, this term is imprecise and leaves
us with little information on the exact precautions that the
majority of respondents would be prepared to take. In a
Table 2: Lay people's anticipations of fatalities and effect of Tamiflu® during a serious influenza epidemica
Absolute (baseline) risk (number of 
fatalities in a population of 4.6 mill)
Relative to the authorities' mortality 
predictionb
Proportion of respondents (n = 1168)
0.0002% – 0.02% Below 48 %
0.04% – 1.1% Similar 22 %
2.2% – 22% Above 3 %
Uncertain 27 %
Relative risk reduction from Tamiflu®
< 50 % 24 %
50 – 100% 24 %
Inconsistent (ARRb > baseline risk) 3 %
Uncertain 48 %
Number needed to treat
< 1000 9 %
> 1000 41 %
Inconsistent (ARRc>baseline risk) 3 %
Uncertain 47 %
a) Estimated from the respondents' anticipated number of fatalities and number of fatalities averted by Tamiflu®, relative to a total population of 4.6 
million.
b) The Norwegian Institute of Public Health states that 0.05%–1% of the population might die during an influenza pandemic
c) ARR = absolute risk reductionBMC Public Health 2007, 7:48 http://www.biomedcentral.com/1471-2458/7/48
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paper on non-pharmaceutical interventions for pandemic
influenza, the World Health Organization states that there
is limited evidence for an effect of face mask, "cough eti-
quette" or handwashing [9].
There are few similar studies reported. In a study of US
public health workers, nearly half of them reported that
they were likely not to report to duty during an influenza
epidemic [10]. It should be noted that study location, type
of respondents and type of survey was quite different.
Tamiflu® is perceived by many as an effective drug against
influenza fatalities, but few had got hold of the drug at the
time of the survey (November 2005). Sales data indicate
that about 1% of the Norwegian population has pur-
chased Tamiflu®  during the subsequent 5 months. It
should be noted, however, that health authorities and the
Medical Association advised GPs against prescribing
Tamiflu® as a precaution except in special circumstances. A
review questioned the effectiveness of antivirals for sea-
sonal influenza, but the relevance of this in the context of
influenza pandemic is unclear [11]. The government
stockpiling of Tamiflu® may have further reduced the per-
ceived need to purchase it personally.
In a recent paper, the authors warn against a "pandemic of
panic" [12]. Our results, however, indicate that only a
minority of the population perceive the risk as greater
than health authorities do, and most people indicate that
they will take some, but not overly disruptive, precautions
if a pandemic breaks out.
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Appendix – The questionnaire
Q1: If a serious influenza epidemic should break out in
Norway – what do you think you would do? (please,
tick one or more options)
O No special measures
O Be careful about personal hygiene
O Use face mask outdoor
O Keep away from work
O Stay at home and avoid contact with others
O Go to a remote place like country cottage, farm or other
Q2: How many people would you think are going to die
in Norway if a serious influenza breaks out? (please,
tick one option)
O 10
O 50
O 100
O 250
O 500
O 1.000
O 2.000
O 4.000
O 7.000
O 10.000
O 25.000
O 50.000
O 100.000
O 250.000
O 500.000
O 1.000.000
O Uncertain
Q 3: How many fatalities do you think could be avoided
if the drug Tamiflu were available to everybody?
(please, tick one option)
O 10
O 50
O 100
O 250
O 500BMC Public Health 2007, 7:48 http://www.biomedcentral.com/1471-2458/7/48
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O 1,000
O 2,000
O 4,000
O 7,000
O 10,000
O 25,000
O 50,000
O 100,000
O 250,000
O 500,000
O 1,000,000
O Uncertain
Q4: How much would you at maximum be willing to pay
in order to have a course of Tamiflu drug available in
case you would need it? (please, tick one option)(€1.00
= NOK8.00)
O Less than NOK 50
O NOK 50
O NOK 100
O NOK 250
O NOK 500
O NOK 1.000
O NOK 1.500
O NOK 2.000
O NOK 3.000
O NOK 5.000
O NOK 7.500
O NOK 10.000
O More than NOK 10.000
Q5. Have you got hold of Tamiflu to yourself or your
closest family members?
O Yes
O No
Q6. How is your health status? (please, tic kone option)
O Poor
O Not so good
O Quite good
O Very good
Q7. From what sources have you received information
about influenza? (please, tic kone or more options)
O Newpapers
O Weekly magazines
O TV
O The website of the National Public Health Institute
O The "influenza-phone" of the National Public Health
Institute
O The website of the Directorate for Health and Social
Affairs
O The Norwegian Food Safety Authority
O Your general practitioner
O Other
Q8. Do you trust the information provided by authori-
ties about influenza-situation?
O Yes
O No
O Uncertain
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